INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Quarterly Results

Change Company Name

Aurobindo Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 524804	ISIN Demat INE406A01037	Book Value 335.47	NSE Symbol AUROPHARMA	Dividend Yield (%) 0.38	Market Cap (₹ Cr.) 68,669.08	P/E 35.82	EPS 32.72	Face Value 1

Particulars (₹ Cr)	Dec 2024	Sep 2024	Jun 2024	Mar 2024

Gross Sales/Income from operations	2883.56	2757.88	2425.22	2866.4
Less: Excise duty	0.00	0.00	0.00	0.00
Net Sales/Income from operations	2,883.56	2,757.88	2,425.22	2,866.40
Other Operating Income	33.07	66.71	34.87	27.63
Total Income from operations (net)	2,916.63	2,824.59	2,460.09	2,894.03
Total Expenses	2,271.76	2,171.87	2,028.04	2,184.05
Cost of Sales	1,464.28	1,409.65	1,296.22	1,405.47
Employee Cost	265.15	265.48	259.33	248.91
Depreciation, amortization and depletion expense	68.28	68.16	66.88	64.81
Provisions & Write Offs	0.00	0.00	0.00	0.00
Administrative and Selling Expenses	0.00	0.00	0.00	0.00
Other Expenses	474.05	428.58	405.61	464.86
Pre Operation Expenses Capitalised	0.00	0.00	0.00	0.00
Profit from operations before other income, finance costs and exceptional items	644.87	652.72	432.05	709.98
Other Income	54.26	122.66	65.32	122.97
Profit from ordinary activities before finance costs and exceptional items	699.13	775.38	497.37	832.95
Finance Costs	66.19	51.63	51.13	53.07
Profit from ordinary activities after finance costs but before exceptional items	632.94	723.75	446.24	779.88
Exceptional Items	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00
Profit from ordinary activities before tax	632.94	723.75	446.24	779.88
Total Tax	160.89	186.22	117.20	201.21
Net profit from Ordinary Activities After Tax	472.05	537.53	329.04	578.67
Profit / (Loss) from Discontinued Operations	0.00	0.00	0.00	0.00
Net profit from Ordinary Activities/Discontinued Operations After Tax	472.05	537.53	329.04	578.67
Extraordinary items	0.00	0.00	0.00	0.00
Other Adjustments After Tax	0.00	0.00	0.00	0.00
Net Profit after tax for the Period	472.05	537.53	329.04	578.67
Other Comprehensive Income	-1.45	-2.48	-0.42	-0.36
Total Comprehensive Income	470.60	535.05	328.62	578.31
Equity	58.08	58.08	58.59	58.59
Reserve & Surplus	0.00	19,598.16	0.00	0.00
Face Value	1.00	1.00	1.00	1.00
EPS:
EPS before Exceptional/Extraordinary items-Basic	8.13	9.21	5.62	9.88
EPS before Exceptional/Extraordinary items-Diluted	8.13	9.21	5.62	9.88
EPS after Exceptional/Extraordinary items-Basic	8.13	9.21	5.62	9.88
EPS after Exceptional/Extraordinary items-Diluted	8.13	9.21	5.62	9.88
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00
Dividend Per Share(Rs.)	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00
No. of Employees	0.00	0.00	0.00	0.00
Debt Equity Ratio	0.00	0.00	0.00	0.00
Debt Service Coverage Ratio	0.00	0.00	0.00	0.00
Interest Service Coverage Ratio	0.00	0.00	0.00	0.00
Debenture Redemption Reserve (Rs cr)	0.00	0.00	0.00	0.00
Paid up Debt Capital (Rs cr)	0.00	0.00	0.00	0.00